Eli Lilly & Co. (LLY) Social Stream
ELI LILLY & CO (LLY) Price Targets From Analysts
Use the tables below to see what analysts covering ELI LILLY & CO think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-27 | 12 | $315 | $183 | $272.666 | $601.1 | -54.64% |
| 2021-11-19 | 12 | $315 | $183 | $275.615 | $601.1 | -54.15% |
| 2021-12-08 | 12 | $315 | $183 | $278.615 | $601.1 | -53.65% |
| 2021-12-15 | 13 | $315 | $250 | $285.307 | $601.1 | -52.54% |
| 2021-12-16 | 13 | $335 | $250 | $290.615 | $601.1 | -51.65% |
| 2021-12-20 | 13 | $335 | $265 | $299.076 | $601.1 | -50.25% |
| 2022-01-12 | 13 | $335 | $265 | $299.846 | $601.1 | -50.12% |
| 2022-02-04 | 12 | $335 | $265 | $299.846 | $601.1 | -50.12% |
| 2022-02-14 | 12 | $335 | $265 | $299.307 | $601.1 | -50.21% |
| 2022-02-24 | 12 | $335 | $265 | $298.615 | $601.1 | -50.32% |
| 2022-03-10 | 12 | $335 | $265 | $297.714 | $601.1 | -50.47% |
| 2022-03-17 | 12 | $335 | $265 | $298.785 | $601.1 | -50.29% |
| 2022-04-18 | 12 | $364 | $265 | $305.857 | $601.1 | -49.12% |
| 2022-04-29 | 12 | $364 | $265 | $309.428 | $601.1 | -48.52% |
| 2022-05-10 | 12 | $369 | $265 | $321.714 | $601.1 | -46.48% |
| 2022-05-25 | 13 | $369 | $264 | $319.312 | $601.1 | -46.88% |
| 2022-06-15 | 13 | $369 | $264 | $320.25 | $601.1 | -46.72% |
| 2022-07-22 | 14 | $395 | $264 | $329.062 | $601.1 | -45.26% |
| 2022-08-05 | 13 | $395 | $264 | $330.625 | $601.1 | -45% |
| 2022-08-24 | 14 | $395 | $264 | $331 | $601.1 | -44.93% |
| 2022-08-31 | 14 | $395 | $264 | $337.562 | $601.1 | -43.84% |
| 2022-09-07 | 14 | $396 | $264 | $342.312 | $601.1 | -43.05% |
| 2022-09-21 | 14 | $412 | $264 | $344.312 | $601.1 | -42.72% |
| 2022-09-28 | 15 | $412 | $264 | $346.294 | $601.1 | -42.39% |
| 2022-10-31 | 14 | $408 | $264 | $347.529 | $601.1 | -42.18% |
| 2022-11-02 | 14 | $408 | $264 | $351.058 | $601.1 | -41.6% |
| 2022-11-08 | 14 | $441 | $286 | $368.058 | $601.1 | -38.77% |
| 2022-11-15 | 14 | $441 | $286 | $369.294 | $601.1 | -38.56% |
| 2022-11-16 | 15 | $436 | $286 | $369 | $601.1 | -38.61% |
| 2022-11-30 | 15 | $436 | $286 | $373.117 | $601.1 | -37.93% |
| 2022-12-06 | 16 | $436 | $286 | $375.47 | $601.1 | -37.54% |
| 2022-12-08 | 16 | $446 | $286 | $378 | $601.1 | -37.12% |
| 2022-12-13 | 16 | $446 | $286 | $381.611 | $601.1 | -36.51% |
| 2022-12-14 | 16 | $446 | $286 | $382.722 | $601.1 | -36.33% |
| 2022-12-16 | 16 | $446 | $286 | $384.166 | $601.1 | -36.09% |
| 2023-01-19 | 16 | $446 | $286 | $384 | $601.1 | -36.12% |
| 2023-02-01 | 16 | $446 | $286 | $389.47 | $601.1 | -35.21% |
| 2023-02-03 | 16 | $446 | $286 | $388.588 | $601.1 | -35.35% |
| 2023-02-27 | 16 | $455 | $286 | $389.117 | $601.1 | -35.27% |
| 2023-03-03 | 18 | $444 | $286 | $387.882 | $601.1 | -35.47% |
| 2023-03-06 | 18 | $444 | $286 | $382.444 | $601.1 | -36.38% |
| 2023-03-31 | 18 | $444 | $310 | $390.176 | $601.1 | -35.09% |
| 2023-04-05 | 18 | $444 | $313 | $393.562 | $601.1 | -34.53% |
| 2023-04-10 | 18 | $448 | $313 | $393.812 | $601.1 | -34.48% |
| 2023-04-11 | 18 | $448 | $313 | $393.25 | $601.1 | -34.58% |
| 2023-04-27 | 18 | $445 | $313 | $393.062 | $601.1 | -34.61% |
| 2023-04-28 | 18 | $485 | $313 | $407.875 | $601.1 | -32.15% |
| 2023-05-01 | 18 | $485 | $313 | $412.125 | $601.1 | -31.44% |
| 2023-05-03 | 18 | $485 | $313 | $417.75 | $601.1 | -30.5% |
| 2023-05-15 | 18 | $505 | $313 | $427.375 | $601.1 | -28.9% |
| 2023-05-23 | 18 | $507 | $313 | $429.187 | $601.1 | -28.6% |
| 2023-05-24 | 18 | $507 | $313 | $436.687 | $601.1 | -27.35% |
| 2023-06-13 | 18 | $507 | $313 | $440.437 | $601.1 | -26.73% |
| 2023-06-27 | 18 | $507 | $313 | $450 | $601.1 | -25.14% |
| 2023-06-28 | 18 | $550 | $313 | $459.062 | $601.1 | -23.63% |
| 2023-07-11 | 18 | $551 | $313 | $461.812 | $601.1 | -23.17% |
| 2023-07-18 | 18 | $560 | $313 | $467.588 | $601.1 | -22.21% |
| 2023-07-21 | 18 | $565 | $313 | $476.705 | $601.1 | -20.69% |
| 2023-07-26 | 18 | $565 | $313 | $488.235 | $601.1 | -18.78% |
| 2023-07-28 | 18 | $565 | $313 | $490.294 | $601.1 | -18.43% |
| 2023-08-09 | 18 | $633 | $392 | $558.47 | $601.1 | -7.09% |
| 2023-09-07 | 18 | $640 | $392 | $569.529 | $601.1 | -5.25% |
| 2023-10-05 | 18 | $640 | $392 | $577.47 | $601.1 | -3.93% |
| 2023-10-09 | 18 | $700 | $392 | $586 | $601.1 | -2.51% |
| 2023-10-17 | 18 | $700 | $470 | $604.294 | $601.1 | 0.53% |
| 2023-10-21 | 18 | $700 | $470 | $609.294 | $601.1 | 1.36% |
| 2023-11-03 | 18 | $722 | $470 | $624.411 | $601.1 | 3.88% |
| 2023-11-08 | 18 | $722 | $470 | $627.352 | $601.1 | 4.37% |
| 2023-11-10 | 19 | $722 | $470 | $622.222 | $601.1 | 3.51% |
| 2023-11-15 | 19 | $722 | $470 | $624.333 | $601.1 | 3.87% |
| 2023-11-24 | 19 | $722 | $470 | $629.888 | $601.1 | 4.79% |
The Trend in the Analyst Price Target
Over the past 27 months, LLY's average price target has gone up $367.65.
Over the past 51 weeks, LLY's average upside potential has been 5.8%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-13 | 16 | 446 | 286 | 384.000 | 361.62 | 6.19% |
| 2023-01-19 | 16 | 446 | 286 | 384.000 | 351.08 | 9.38% |
| 2023-10-09 | 18 | 700 | 392 | 583.941 | 571.76 | 2.13% |
| 2023-11-03 | 18 | 710 | 470 | 615.058 | 567.81 | 8.32% |
| 2023-11-24 | 19 | 722 | 470 | 629.888 | 601.10 | 4.79% |
LLY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.24 | 16 | 1 | 2 | 0 | 0 | 19 |
The Trend in the Broker Recommendations
LLY's average broker recommendation rating improved by 0.12 over the prior 17 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- LLY has a greater average analyst price target than 9196.07% of all US stocks.
- In terms of how ELI LILLY & CO fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 247.65% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ELI LILLY & CO's number of analysts covering the stock is higher than 8388.35% of them.
- LLY has a lower variance in analysts' estimates than -2289.51% of Pharmaceutical Products stocks.
Stocks similar to ELI LILLY & CO in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ABT, BNTX, and MRNA.
View All Top Stocks by Price Target
Make investment decisions regarding LLY using the data that counts. Try POWR Ratings for free.